E
Kane Biotech Inc. KNBIF
$0.0328 $0.005520.15% OTC PK
Recommendation
Prev Close
Volume
Avg Vol (90D)
Market Cap
Dividend & Yield
--
52-Week Range
P/E (TTM)
--
EPS (TTM)

06/30/2025 03/31/2025 12/31/2024 09/30/2024 06/30/2024
Revenue 141.30% 1,344.70% 1,281.40% 210.74% 160.69%
Total Other Revenue -- -- -- -- --
Total Revenue 141.30% 1,344.70% 1,281.40% 210.74% 160.69%
Cost of Revenue 354.50% 3,358.41% 2,919.86% 218.03% 154.13%
Gross Profit 2.44% 612.46% 690.86% 204.15% 165.88%
SG&A Expenses -30.74% 21.12% 26.29% 291.74% 166.67%
Depreciation & Amortization -- -- -- -- --
Other Operating Expenses -- -- -- -- --
Total Operating Expenses -13.10% 55.82% 63.76% 630.07% 301.66%
Operating Income 38.80% 2.44% -9.64% -56.49% -77.09%
Income Before Tax 41.33% 17.84% 3.25% -23.19% -44.30%
Income Tax Expenses -- -- -- -- --
Earnings from Continuing Operations 64.48% 43.40% 30.96% -23.19% -44.30%
Earnings from Discontinued Operations -111.70% 3,258.52% 2,042.75% 2,611.65% 3,755.94%
Extraordinary Item & Accounting Change -- -- -- -- --
Minority Interest in Earnings -- -- -- -- --
Net Income -166.27% 220.19% 219.94% 231.00% 222.17%
EBIT 38.80% 2.44% -9.64% -56.49% -77.09%
EBITDA 39.39% 1.30% -10.66% -57.98% -79.66%
EPS Basic -161.92% 220.67% 216.44% 226.23% 214.54%
Normalized Basic EPS 50.52% 27.68% 11.52% -21.28% -44.78%
EPS Diluted -223.13% 168.17% 163.08% 162.45% 161.78%
Normalized Diluted EPS 49.20% 30.46% 14.20% -18.84% -42.75%
Average Basic Shares Outstanding 11.78% 7.44% 5.34% 6.56% 6.24%
Average Diluted Shares Outstanding 9.74% 8.00% 5.99% 7.17% 6.87%
Dividend Per Share -- -- -- -- --
Payout Ratio -- -- -- -- --